NAV
$27.35
AUM
$4.5M
Expense Ratio
-
Dividend Yield
0.00%
Beta
0.00
Currency
USD
| YTD | 1M | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|
| -0.22% | +14.00% | +33.46% | -25.75% | - | - |
| # | Symbol | Name | Weight |
|---|---|---|---|
| 1 | NVO | Novo Nordisk AS ADR | 95.99% |
The series, under normal circumstances, invests at least 95% of its net assets in American Depositary Receipts (“ADRs”) of the Novo Nordisk A/S (B Shares) (the “Company”). The series will not invest directly in the company. The fund is non-diversified.
Inception Date: 2025-01-06